http://www.businesswire.com/news/home/20260531161413/en/Ivonescimab-with-Chemotherapy-Demonstrated-a-Statistically-Significant-Overall-Survival-Benefit-Compared-to-Tislelizumab-Plus-Chemotherapy-in-1L-Treatment-of-Patients-with-Squamous-NSCLC-in-the-HARMONi-6-Study-Conducted-by-Akeso-in-China 2026-05-31T06:06:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260531652876/en/Tempus-Unveils-the-Next-Generation-of-Lens-Expanding-its-Agentic-AI-Platform-for-Oncology-Drug-Development 2026-05-31T05:30:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260531990280/en/Pfizer%E2%80%99s-BRAFTOVI-Regimen-Nearly-Doubles-Median-Progression-Free-Survival-in-Metastatic-Colorectal-Cancer 2026-05-31T05:00:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260531412768/en/Kelonia-Therapeutics-Presents-Updated-First-in-Human-Data-from-Phase-1-inMMyCAR-Study-of-KLN-1010-in-vivo-BCMA-CAR-T-Therapy-at-the-2026-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting 2026-05-31T05:00:00.000-07:00 weekly 0.5